In addition, Deng et al. showed ENO1 binds to AKT, activating CCND1 expression downstream, while CCDC65 assists ENO1 degradation via FBXW7, thereby inhibiting GC progression [25]. The gene discussed is DRC2; the disease is gastric cancer.